Tài liệu tham khảo |
Loại |
Chi tiết |
1. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, et al. Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation. 2011;123(4):e18-e209 |
Sách, tạp chí |
|
2. Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K. Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2007;115(5):e69-171 |
Sách, tạp chí |
|
6. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. N Engl J Med.1971;285(26):1441-6 |
Sách, tạp chí |
|
7. Francis GS, Benedict C, Johnson DE, Kirlin PC, Nicklas J, Liang CS, et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation. 1990;82(5):1724-9 |
Sách, tạp chí |
|
8. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandanavian Enalapril Survival Study (CONSENSUS). The Consensus Trial Study Group. N Engl J Med. 1987;316(23):1429-35 |
Sách, tạp chí |
|
9. Grag R, Yusuf S. Overview of randomized trials of angiotensin-converting inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials. JAMA. 1995;273(18):1450-6 |
Sách, tạp chí |
|
10. Packer M, Coats AJ, Fowler MB, Katus HA, Krum H, Mohacsi P, et al. Effect of carvedilol on survival in severe chronic heart heart failure. N Engl J Med.2001;344(22):1651-8 |
Sách, tạp chí |
|
11. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, et al. The effects of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl. J Med.1996;334(21):1349-55 |
Sách, tạp chí |
|
12. Effect of metoprolol CR/XL in chronic heart failure: Randomized Intervention Trial in Congestive Heart Failure (Merit-HF). Lancet. 1999;353(9169);2001-7 |
Sách, tạp chí |
|
13. The Cardiac Insufficiency Bisoprolol Study II (CIBIS II): a randomized trial. Lancet. 1999;353(9146):9-13 |
Sách, tạp chí |
|
14. Flather MD, Shibata MC, Coats AJ, Van Veldhuisen DJ, Parkhomenko A, Borbola J, et al. Randomized trial to determine the effect of nebivolol on mortality and mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J. 2005;26(3):215-25 |
Sách, tạp chí |
|
15. Poole-Wilson PA, Swedberg K, Cleland JG, Di Lenarda A, Hanrath P, Komajda M, et al. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomized controlled trial. Lancet. 2003;362(9377):7-13 |
Sách, tạp chí |
|
16. Beta-Blocker Evaluation of Survival Trial Investigators. A trial of beta-blocker bucindolol in patients with advanced heart failure. N Engl J Med. 2001;344(22):1659-67 |
Sách, tạp chí |
|
17. Maack C, Cremers B, Flesch M, Hửper A, Sỹdkamp M, Bửhm M. Different intrinsic activities of bucindolol, carvediloland metoprolol in human failing myocardium.Br J Pharmacol. 2000;130(5):1131-9 |
Sách, tạp chí |
|
18. Andreka P, Aiyar N, Olson LC, Wei JQ, Turner MS, Webster KA, et al. Bucindilol displays intrinsic sympathomimetic activity in human myocardium. Circulation.2002;105(20):2429-34 |
Sách, tạp chí |
|
19. Cohn JN, Pfeffer MA, Rouleau J, Sharpe N, Swedberg K, Straub M, et al. Adverse mortality effect of central sympathetic inhibition with sustained-release monoxodine in patients with heart failure (MOXCON). Eur J Heart Failure.2003;5(5):659-67 |
Sách, tạp chí |
Tiêu đề: |
Eur J Heart Failure |
|
20. MacFadyen RJ, Barr CS, Struthers AD. Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients. Cardiovasc Res. 1997;35(1):30-4 |
Sách, tạp chí |
|
21. Iraqi W, Rossignol P, Angiol M, Fay R, Nuée J, Ketelslegers JM, et al. Extracellular cardiac matrix biomarkers in patients with acute myocardial infarction complicated by left ventricular dysfunction and heart failure: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS). Circulation. 2009;119(18):2471-9 |
Sách, tạp chí |
|
22. Tsutamo T, Wada A, Maceda K, Mabuchi N, Hayashi M, Tsutsui T, et al. The effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure. J Am Coll Cardiol. 2001;37(5):1228-33 |
Sách, tạp chí |
Tiêu đề: |
J Am Coll Cardiol |
|
24. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure.Randomized Evaluation Study Investigators. N Engl J Med. 1999;341(10):709-17 |
Sách, tạp chí |
|